0.8002
Movano Inc Aktie (MOVE) Neueste Nachrichten
Movano Health's Proprietary Cuffless Blood Pressure Device Once Again Achieves Accuracy Commensurate with the FDA's Requirements - PR Newswire
Movano May Issue And Sell From Time To Time, Up To $8.9 Million Of Common Stock - marketscreener.com
Movano Inc. SEC 10-K Report - TradingView
Movano stock hits 52-week low at $1.14 amid market challenges By Investing.com - Investing.com South Africa
Movano stock hits 52-week low at $1.14 amid market challenges - Investing.com Australia
Movano Inc. Delays Annual Report Filing - TipRanks
Movano stock hits 52-week low at $1.83 amid market challenges By Investing.com - Investing.com South Africa
Movano stock hits 52-week low at $1.83 amid market challenges - Investing.com India
Movano stock hits 52-week low at $2.53 amid market challenges - Investing.com Australia
Movano stock hits 52-week low at $2.53 amid market challenges By Investing.com - Investing.com South Africa
Movano's Evie Ring Adds New Personalization and Trend Tracking to Support Women's Wellness Journey - PR Newswire
Evie Ring App Update Brings Apple Health Integration, Enhanced Sleep Tracking - Stock Titan
Movano stock hits 52-week low at $2.75 amid market challenges - Investing.com
(MOVE) Technical Data - Stock Traders Daily
Movano Starts Cuffless Blood Pressure Wearable Device Clinical Study -February 04, 2025 at 10:53 am EST - Marketscreener.com
Movano Health Commences Clinical Study with New Cuffless Blood Pressure Device - WV News
Movano Health Launches EvieAI Virtual Wellness Assistant - Quantisnow
Movano Appoints Shaheen Wirk to Board of Directors - TipRanks
Movano Health expands board with healthcare investment expert By Investing.com - Investing.com Canada
Movano Health Welcomes Dr. Shaheen Wirk to its Board of Directors - PR Newswire
Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split - Longview News-Journal
Movano Health Provides Update on FDA Review of EvieMED Ring - Kilgore News Herald
Movano (NASDAQ:MOVE) versus Pixie Dust Technologies (NASDAQ:PXDT) Financial Analysis - Defense World
Movano receives FDA nod for smart ring’s pulse oximeter feature - MedTech Dive
Movano Health gets FDA clearance for its EvieMED Ring - Gadgets & Wearables
Movano rings up FDA pulse ox clearance for Eviemed - BioWorld Online
Movano Health's EvieMED Ring Secures FDA Clearance, Targets $40B Healthcare Market - StockTitan
Movano Health Receives FDA Clearance for EvieMED Ring - PR Newswire
Movano Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Movano stock hits 52-week low at $3.01 amid market challenges - Investing.com
Movano Inc. (NASDAQ:MOVE) Q3 2024 Earnings Call Transcript - MSN
Movano Focuses on EvieMED Ring FDA Review and New B2B Partnerships - Sleep Review
Movano Health Updates on Financial and Strategic Progress - TipRanks
Movano Health Narrows Losses, Advances Evie Ring Sales and FDA Clearance Push | MOVE Stock News - StockTitan
Movano Health Reports Q3 2024 Financial Results and Provides Business Update - PR Newswire
Head to Head Survey: Movano (NASDAQ:MOVE) versus Integer (NYSE:ITGR) - Defense World
MOVEMovano Inc. Latest Stock News & Market Updates - StockTitan
Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device - PR Newswire
Movano Health to Report Third Quarter 2024 Financial Results on Thursday November 14, 2024 - StockTitan
Movano seeks FDA clearance for EvieMED health ring By Investing.com - Investing.com Canada
Movano Health investigates stock manipulation post-split By Investing.com - Investing.com Canada
Movano sumitts complete EvieMED Ring response package to the FDA - TipRanks
Movano provides update on investigation regarding apparent manipulation - TipRanks
Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split - PR Newswire
Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED - PR Newswire
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):